An analysis of the development and implementation of a smartphone application for the delivery of antimicrobial prescribing policy: lessons learnt by Charanil, E et al.
An analysis of the development and implementation of a smartphone
application for the delivery of antimicrobial prescribing policy:
lessons learnt
E. Charani1*, Y. Kyratsis1, W. Lawson2, H. Wickens2, E. T. Brannigan2, L. S. P. Moore2 and A. H. Holmes1
1The National Centre for Infection Prevention and Management, Imperial College London, London, UK; 2Imperial College Healthcare NHS
Trust, London W12 0HS, UK
*Corresponding author. Tel: +44-(0)203-313-1553; Fax: +44-(0)208-383-3394; E-mail: e.charani@imperial.ac.uk
Received 12 October 2012; returned 31 October 2012; revised 9 November 2012; accepted 14 November 2012
Objectives: Smartphone usage amongst clinicians is widespread. Yet smartphones are not widely used for the
dissemination of policy or as clinical decision support systems. We report here on the development, adoption
and implementation process of the Imperial Antimicrobial Prescribing Application across five teaching hospitals
in London.
Methods: Doctors and clinical pharmacists were recruited to this study, which employed a mixed methods in-
depth case-study design with focus groups, structured pre- and post-intervention survey questionnaires and
live data on application uptake. The primary outcome measure was uptake of the application by doctors
and its acceptability. The development and implementation processes were also mapped.
Results: The application was downloaded by 40% (376) of junior doctors with smartphones (primary target
user group) within the first month and by 100% within 12 months. There was an average of 1900 individual
access sessions per month, compared with 221 hits on the Intranet version of the policy. Clinicians (71%)
reported that using the application improved their antibiotic knowledge.
Conclusions: Clinicians rapidly adopted the mobile application for antimicrobial prescribing at the point of care,
enabling the policy to reach a much wider audience in comparison with paper- and desktop-based versions of
the policy. Organizations seeking to optimize antimicrobial prescribing should consider utilizing mobile technol-
ogy to deliver point-of-care decision support. The process revealed a series of barriers, which will need to be
addressed at individual and organizational levels to ensure safe and high-quality delivery of local policy at
the point of care.
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Introduction
Evidence-based medicine has driven the use of formal policies in
clinical decision making, with international and national guide-
lines for clinical practice being used to develop these policies. A
wealth of literature reports on adherence of healthcare profes-
sionals to local clinical policies as a marker for patient safety
and treatment efficacy.1,2 One area where the impact of local
policy and guidelines is well documented is in the treatment of
infection.1 The provision of local policy, guidelines and clinical
decision-making tools to prescribers has been shown to be an ef-
fective means of optimizing antimicrobial prescribing.1,2 In
efforts to improve clinical practice and adherence in this field,
healthcare institutions are constantly developing innovative
ways to widen access to local policy and guidelines, including
the use of pocket guides, posters, the Internet and electronic
prescribing tools.1
Timely access to medical information is a key factor in ensur-
ing effective and safe medical practice.3 Technology has the po-
tential of improving accessibility to data and resources.4 The use
of smartphone technology by healthcare professionals can help
improve standards of care, while the ubiquitous use of smart-
phones has also influenced the way in which evidence-based
medicine is communicated to healthcare professionals.5 There
is now an ever-increasing choice of commercial medical
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applications available for download on smartphones. Amongst
these, a number are dedicated to the diagnosis and treatment
of infectious diseases.6 The convenient ‘pocketable’, ‘anywhere,
anytime’ access to medical information via smartphones is an
attractive prospect for healthcare professionals increasingly at
ease with mobile technology.7,8 In light of the proliferation of
mobile technology in healthcare, the US FDA and the European
Commission have issued interim guidelines, initiating the devel-
opment of standards and definitions for the use of mobile tech-
nology in healthcare.9,10
Given the high rates of adoption of smartphones in the
medical community5,11 and the increasing number of medical
software applications being developed,6,12 the use of smart-
phones as a point of access to local policy resonates with the
broader strategy of utilizing electronic health (‘eHealth’) and
mobile communications to contribute towards high-quality and
safe healthcare.13–15 An understanding of the potential risks
and benefits of mainstreaming mobile health technology inter-
ventions in the field of antimicrobial prescribing is critical, given
the increasing use by clinicians and high levels of interest by
healthcare organizations and policy makers. Yet, to date, there
has been no in-depth systematic risk assessment. The ubiquitous
use of mobile technology, especially smartphones in clinical set-
tings, offers an ideal platform for the dissemination of
point-of-care medical information to clinicians. Despite this,
there exists a level of scepticism by healthcare professionals
towards the use of innovative technologies, and this has a
direct impact on their adoption and consistent use.16 This is
the result of a series of barriers and lack of information and
knowledge that is required to use an innovation properly at
both the individual and organizational levels.17,18
At Imperial College Healthcare NHS Trust (ICHT), which con-
sists of five teaching hospitals at three sites in West London,
the antimicrobial prescribing policy is available to clinicians in
many formats, including a poster, pocket guide and on the
Trust’s Intranet. In this study, we report on the development of
the policy into a free smartphone application known as the
‘IAPP’ (Imperial Antibiotic Prescribing Policy) and its uptake and
acceptability amongst clinicians. Furthermore, we map quantita-
tively and qualitatively the adoption process and discuss the
identified barriers and potential unwanted consequences at the
individual and organizational levels of implementing a mobile
application for antimicrobial prescribing, and provide potential
solutions to addressing them.
Methods
Design
The development of the IAPP was clinician-led and supported by the or-
ganizational hierarchy using resources from the academic research unit
based at Imperial College, London. The IAPP was developed in iterative
stages. We employed an in-depth case-study design, which involved
both qualitative and quantitative methods of inquiry that informed
each other and enabled triangulation of the findings.19 The selected
design was appropriate to our study, which aimed to explore the technol-
ogy journey in-depth and systematically search for potential risks and
benefits to individuals and organizations during the implementation
process. Ethical approval was obtained from the Imperial Joint Research
Office, who confirmed that this work did not require submission to the
Multi Centre Research Ethics Committee.
Data were collected from observational notes and the minutes taken
during three focus group meetings in the early stages of development of
the application, structured pre- and post-intervention (1 year after intro-
duction) survey questionnaires (see Supplementary data, available at JAC
Online) and real-time quantitative data on downloads and use of the ap-
plication by clinicians over a period of 1 year. The pre-intervention survey
of clinicians was used to assess: (i) the local prevalence of smartphone
use amongst clinicians; (ii) clinicians’ awareness and usage of the existing
antibiotic policy; and (iii) their experience of using external clinical appli-
cations on their smartphones. The results of the pre-intervention ques-
tionnaire were used to inform the development of the IAPP. A software
company was employed to develop the user interface of the application
to our specifications. The focus groups comprised both consultant and
junior doctors and pharmacists.
To garner opinions and feedback from users, the post-intervention
structured questionnaire was designed and disseminated 1 month and,
again, 1 year after the launch of the IAPP. Post-intervention data collec-
tion allowed sufficient time for the early adoption and diffusion of the
product by target users. The method of dissemination was the same
as for the pre-intervention questionnaire. Doctors attending training ses-
sions at the postgraduate centres of the three hospital sites were asked
to complete the questionnaire during two consecutive weeks. Pharma-
cists were e-mailed the questionnaire with a covering message explaining
its purpose. A reminder e-mail was sent after 2 weeks.
Setting and time period
The study was conducted in 2011–12 over a period of 16 months, from
April 2011 (inception) to July 2012 (1 year post-intervention assessment).
ICHT, which consists of five teaching hospitals at three sites in West
London, was purposefully selected as the research setting. The develop-
ment process began in April 2011 and lasted 4 months. The launch
date of the application was in the first week of August 2011, to coincide
with the intake of newly qualified doctors. This provided an opportunity to
maximize on the uptake and diffusion of the application amongst junior
medical staff, who were the primary target group of the intervention.
Participants and sampling
Each of the postgraduate centres on the three sites holds two training
sessions per week, with an average attendance of 30 doctors at each.
Therefore, in total, the number of doctors the questionnaires could
have been distributed to is 360. There are 90 clinical pharmacists
across the sites and the questionnaires were e-mailed to all of them.
Three focus group meetings were held over the course of the study.
Focus group members included all the relevant stakeholders involved in
the development and adoption of the application. At least one consult-
ant, one junior doctor and one specialist antibiotic pharmacist partici-
pated in every focus group session.
Primary outcome measure
The primary outcome measure was the uptake of the application (IAPP)
by doctors across the hospitals studied over a period of 12 months. The
entire process of development and implementation was mapped to
provide a detailed measure of the steps and the unwanted conse-
quences, to ensure patient safety and quality of care was assured.
Data analysis
Data from the focus groups and the open-ended questions in the survey
questionnaires were analysed using the framework approach.20 Emerging
themes were categorized according to the perceived risks and benefits
associated with the development and implementation of the innovative
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application. Live data on access to the IAPP were collected via Flurry
Analytics (Portable Pixels, Camden, London, UK; http://portablepixels.
com/), an online analytics interface, which collated, analysed and dis-
played usage data in spreadsheets.
Results
Pre-intervention survey results
Seventy-one doctors and 16 clinical pharmacists responded to
the structured pre-intervention questionnaires. The doctors com-
prised registrars and junior-level trainees. The response rate was
20% (71/360) for doctors and 18% (16/90) for pharmacists.
Eighty-two percent of doctors (58/71) and 75% of pharmacists
(12/16) reported using a smartphone at work. Android and
iPhone devices made up 90% of the smartphones used, with
76% of the respondents stating that they would use a smart-
phone version of the app if it was made available.21 All of the
respondents were aware of the policy. Half of the doctors
reported using commercially available applications to inform
their practice.
Mapping the development and implementation process
Development
The development process included stakeholder input from infor-
mation technology (IT), application designers and the organiza-
tion’s communication team. Additional functionalities, e.g.
creatinine clearance, weight-related dosing in obesity and thera-
peutic drug monitoring functions, were embedded as decision
support tools into the final product. All clinical calculators had
to be validated by the clinical pharmacy team.
During the development process, the IAPP was adapted to the
local context. Due to parts of the hospital sites having very poor
Wi-Fi connectivity and limited Internet access, it was decided
that the app should be ‘native’ and work directly from the
device it is downloaded on. Due to the application containing
contact information for individual staff, it was decided not to
host it on the iTunes store and a separate external uniform re-
source locator (‘URL’) was created from where the app could
be downloaded. The IAPP was username and password pro-
tected and was disseminated to all staff as described below.
The final IAPP product comprised a mobile evolved version of
the policy (Figure 1a and b) with additional functionality, includ-
ing therapeutic drug monitoring and clinical calculators, such as
those for creatinine clearance and ideal and obese body weight
dosing (Figure 1c and d).
The development of the app for iPhone and Android devices
cost £5000 initially, with an additional annual cost of £1500–
2500 for updates. Each additional update to the policy cost
between £400 and £800 during 2011–12. The convenience of
updating the mobile version of the policy means that updates
occur more frequently than the traditional annual update of
the paper version. There were two updates to the policy in
2011–12. The design and printing of the pocket and poster ver-
sions of the policy cost £2000–3000 annually, with an initial
charge of £3000 for design.
Implementation and adoption
The ICHTemployed a multimodal strategy to disseminate the IAPP
using four main communication channels: (i) teaching sessions on
pharmacy for junior doctors in the postgraduate centres at all
three sites; (ii) e-mails sent to all new doctors in the Trust; (iii) the
Intranet homepage that appears each time the Internet browser
is opened on a Trust computer; and (iv) the Trust’s newsletter. In
each case, potential users were providedwith ‘on the spot’ informa-
tion on how to download the application on their smartphones.
The IAPP was launched as a freely available application to all
hospital staff on 1 August 2011. Within the first month of
release, 40% (376) of all new junior doctors had downloaded
the IAPP onto their smartphones (iPhone/Android). The adoption
rate remained steady (Figure 2) throughout the 12 months. One
year after the launch of the application (August 2012), there
were 990 unique users, equivalent to 100% of the primary
target users (junior doctors with smartphones). The average
number of monthly users was 250–300. The monthly average
number of individual sessions on the app is 1900 (Figure 3),
compared with 221 sessions per month on the Intranet version
of the policy. On average, 100 individual sessions were recorded
per day. As part of their regular teaching sessions for junior
doctors, the specialist antibiotic pharmacists provided instructions
for downloading the IAPP. These sessions are indicated in Figure 3
and correspond to a rise in the number of downloads.
Updating the policy
Following a series of changes to the paper policy, the smart-
phone app was updated in June 2012 and again in September
2012, and a pop-up message was sent to all users to update
their mobile devices. During the first update, it was identified
that many people did not remember their password or username
and, to make downloading easier, the password and username
were removed. A more serious problem identified was poor
access to Wi-Fi and the Internet, which disrupted the download
process of the application. Many staff had outdated software on
their mobile phones and were not able to successfully download
the updated application to their mobile devices. In anticipation
of the former, the application was created to work offline as a
native app, but the problems of staff not having updated their
device software had not been anticipated. Furthermore,
making the app ‘native’ as opposed to ‘web based’ meant that
the decision to download the latest version was with the
end-user, as a web-based app would automatically recognize
the latest version of the software from the web provider and
be automatically updated, provided there was sufficient Wi-Fi
access. Each update to the application needs to be updated
across both iPhone and Android devices.
Post-intervention survey results
The post-intervention questionnaire provided feedback and
usage statistics. In total, 81 questionnaires were completed.
This represents a 23% response rate (81/360). The most appeal-
ing features of the IAPP reported by clinical users were its usabil-
ity, accessibility at point of care and transportability. Clinical
decision support features, such as patient group-specific
Charani et al.
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Figure 1. Snapshots of the final IAPP product. Further colour examples of the app are available from www1.imperial.ac.uk/medicine/about/institutes/
cipm/centre_outputs/antimicrobialstewardship.
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prescribing advice, e.g. elderly/frail and penicillin allergy, were
also identified as features most appealing to the end-user. Of
those who provided their opinion, 71% (42/59) considered that
the IAPP added to their knowledge base regarding antimicrobial
prescribing and 81% (48/59) stated that using the app helped
them adhere to the policy. Clinicians were asked for their views
on whether they would feel uncomfortable using the IAPP on
their smartphones in front of patients and 20% (12/60) noted
that they found it difficult to use the app on their smartphones
in this situation. The main reasons provided were that it would
be considered ‘unprofessional’ by patients and because of a per-
ception that using their personal smartphones during work was
against policy.
Discussion
In this study, we found a high level of smartphone usage
amongst junior doctors, who were adept at using smartphone-
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Figure 2. Monthly adoption rate of the application by staff over a 12 month period.
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Figure 3. Using smartphone technology to track the use of policy in real time over its first month of release.
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based clinical applications. This indicates that the methods of
communication used by healthcare organizations are lagging
behind the needs of their technologically advanced employees.
A large proportion of the target audience (40% of junior
medical staff within 1 month) adopted the IAPP. The ease of
adoption and use highlights the user-friendly platform offered
by current smartphones. Furthermore, it indicates that health-
care organizations need to be in line with their staff when it
comes to the use of the right medium for communication and
sharing of information. Organizations aspiring to a sustainable
channel of engagement with their staff need to shift from per-
sonal computer- and paper-based media to mobile technologies.
To make full use of the potential of mobile technology in medical
practice, the IT infrastructure of healthcare organizations needs
to be brought up to date.
The analytic functions of smartphone applications allow for
unprecedented tracking of usage of policy and information in
real time, which has the potential to provide unique insights
into the impact of multimodal interventions on the usage and
application of information in healthcare; in this instance, we
were able to demonstrate the impact of training sessions on
uptake and usage of policy (Figure 3). Most of the peaks in the
use of policy in the first month are attributed to teaching ses-
sions held with junior doctors to inform them about the policy.
The demand for smartphone applications aimed at healthcare
professionals is rapidly growing.6,12 The IAPP aimed to meet
this demand and provide a mobile tailor-made, point-of-care ref-
erence platform developed with user involvement for the dis-
semination of local policy and guidelines targeting prescribing.
In the case of antimicrobial prescribing, providing wider access
to local policy is imperative to efforts to optimize antimicrobial
prescribing, contain antimicrobial resistance and decrease the in-
cidence of healthcare-acquired infections. Overall, we found that
providing the antimicrobial policy as a smartphone application
allowed us to make it available to a wider audience of users,
who reported that using the application helped them adhere to
policy and improved their antimicrobial knowledge.
The diffusion of mobile technology amongst healthcare staff
and the increasing use of this technology to provide medical in-
formation has led to questions about the impact of using mobile
devices in healthcare settings and the potential for disruptions in
care,22 with calls for better regulation.23 Like all new systems
introduced in healthcare, a robust risk assessment is required
to ensure that the unintended consequences of introducing
mobile systems for the provision of ‘on the go’ medical informa-
tion are identified and addressed. We identified several barriers,
both organizational and individual (Table 1), that need to be
recognized to ensure the safe and effective use of mobile tech-
nology to deliver point-of-care decision support in acute care.
Organizational barriers
Policies in healthcare are constantly reviewed and updated in
light of emerging evidence. For a seamless process, applications
need to be web based so that they are automatically updated.
This requires and relies on the availability of network connections
and Wi-Fi in all areas where clinical work is being conducted. At
present, the IT infrastructure of most hospitals in the UK is not
able to assure this high level of access. To address this, IAPP
was developed as a native application. This type of application
relies on individual users to update their applications and the
software on their telephones. When the policy was updated
1 year on, several users had not selected to update their applica-
tion to the latest version. From the perspective of patient safety
and organizational coherence, it is essential that the most
up-to-date version of the policy is used. Some individuals
reported inability to download the application and, when
explored further, it was found that the barrier to adoption
wasn’t the application, but rather end-user unfamiliarity with
the device they were using and not being aware of the need
for regular software updates on their device. For the safe and
effective use of mobile devices, the availability of revisions and
updates should not be reliant on action being taken by the
end-user. Rather, mobile applications capable of being automat-
ically updated need to be developed. To achieve this, organiza-
tions can for instance use ‘cloud technology’, whereby the
servers housing the applications are hosted on the Internet
and accessed via mobile applications. Such systems will require
robust IT support at the organizational level, to ensure they are
accessible in clinical areas where they are of most use as a
point of reference.
Another potential negative influence is the risk of compromis-
ing standardization in the access and use of policies and guide-
lines by staff. Updating the app more frequently and rapidly than
the paper copy means that only healthcare professionals with
smartphones are able to access the up-to-date version of the
Table 1. Barriers to adopting smartphone technology to access an
antimicrobial decision support tool
Organizational barriers Individual barriers
Unintended
consequences of not
addressing barriers
the requirement for
web-based
applications to
enable automatic
update of data and
information
individual end-user’s
need for prompts to
update native
applications—
provision of choice
to end-users may
not be appropriate
application users may
choose not to update
native applications
and not have access
to up-to-date policy to
inform the choices
they make for patients
organizational
commitment to
providing mobile
health (‘mHealth’)
technology across all
available platforms,
e.g. iPhone, Android,
BlackBerry, electronic
tablets
knowledge of the
mobile technology
being used and how
to update software
and upload
applications
correctly
risk of compromising
standardization in
access to and use of
organizational policies
the organizational
culture and policy on
the use of mobile
devices at work
patient and staff
preferences and
beliefs and attitudes
about using mobile
devices in clinical
settings
potential for poor uptake
of the technology and
misinformed beliefs
about the purpose of
using personal devices
during healthcare staff
and patient
consultations
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policy. Retrieving or replacing out-of-date pocket-guide and
printed versions of the policy is not a feasible option. This leads
to problems in the uniformity of practice and can pose a risk to
patient safety if significant changes are made to the mobile
policy, for instance changing the way narrow therapeutic
agents are dosed and monitored. The rapidity and ease of chan-
ging the mobile version in comparison with the paper version of
the policy runs the risk of two different recommendations being
endorsed by the organization, leading to confusion for staff.
However, the appealing feature is that using mobile technology
means that any changes made to policy can be rapidly commu-
nicated with those who are able to access it on their mobile
devices.
Individual barriers
Healthcare professionals who participated in the post-
intervention survey expressed reluctance to using their smart-
phone devices in the presence of patients. This is understand-
able, but it need not be a deterrent as prescribers often refer
to a variety of sources of information as part of their practice,
e.g. web-based guidelines, the British National Formulary and
pocket guides. With the decreasing use of white coats in UK hos-
pitals, doctors are less likely to be able to carry weighty refer-
ences, such as national formularies, in their pockets and
smartphones are a practical alternative source of mobile infor-
mation. The objection to using smartphones in the presence of
patients stems from the social connotations associated with
using mobile devices. Building on this work and developing
further mobile applications for patients as well as for clinicians
can be one way of addressing the perceived negative connota-
tions associated with using smartphones in the work place.
Concerns about the use of mobile devices in healthcare
settings and their potential as a reservoir of infection have
been reported.24–27 Clothing, skin and equipment in the clinical
environment may become transiently contaminated and serve
as a reservoir from which organisms can be transferred to
patients.28,29 Phones carried on the person fall into this category.
The key to protecting patients is effective hand hygiene using
alcohol hand gel between contact with the potentially contami-
nated surface, the smartphone, in this case, and the patient.30
This is a key point that needs to be remembered when weighing
the risks and benefits of using smartphones in the clinical setting.
Study limitations
The development and evaluation process reported here was con-
ducted in real time, following a pragmatic approach alongside
the demands of service delivery across a multisite university
teaching hospital. Some of the authors were system developers
of the application under study; therefore, the possibility for unin-
tended bias in the assessment needs to be acknowledged.
Conclusions
Mobile technology, in particular the smartphone platform, offers
point-of-care access to clinical references and resources and
complements the more traditional platforms of policy dissemin-
ation. In this study, we have identified the rapid uptake and use
of policy by healthcare staff when presented in mobile format.
The process identified key barriers that require addressing in
order to implement mobile technology successfully. Addressing
the IT infrastructure may pave the way for the capability to
support paperless systems, which will address the identified bar-
riers. The future of smartphone application development in
healthcare will depend as much on identifying opportunities for
the use of such technologies, as on strategic action and vision
by policy makers and managers at healthcare organizations, to
integrate electronic and mobile health systems.
Planned future studies into the potential of smartphone tech-
nology as a platform for clinical decision making will include an
evaluation of patient outcomes and clinical quality improvement
in addition to its evaluation as a platform to support training for
staff and as a means of communication with patients towards
more integrated care.
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